Nkarta announces key senior leadership team appointments

South san francisco, calif. , july 25, 2022 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a clinical-stage biopharmaceutical company developing engineered natural killer (nk) cell therapies to treat cancer, today announced the promotions of ralph brandenberger, phd, to chief technical officer and yvonne li, mba, to chief administrative officer.
NKTX Ratings Summary
NKTX Quant Ranking